LANXESS Corporation; Filing of Food Additive Petition (Animal Use)

Published date11 February 2020
Citation85 FR 7682
Record Number2020-02664
SectionProposed rules
CourtFood And Drug Administration
Federal Register, Volume 85 Issue 28 (Tuesday, February 11, 2020)
[Federal Register Volume 85, Number 28 (Tuesday, February 11, 2020)]
                [Proposed Rules]
                [Pages 7682-7683]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2020-02664]
                =======================================================================
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                Food and Drug Administration
                21 CFR Part 573
                [Docket No. FDA-2020-F-0151]
                LANXESS Corporation; Filing of Food Additive Petition (Animal
                Use)
                AGENCY: Food and Drug Administration, HHS.
                ACTION: Notification; petition for rulemaking.
                -----------------------------------------------------------------------
                SUMMARY: The Food and Drug Administration (FDA or we) is announcing
                that LANXESS Corporation has filed a petition proposing that the food
                additive regulations be amended to provide for the safe use of calcium
                formate as a feed acidifying agent, to lower the pH, in complete feeds
                for swine or poultry.
                DATES: The food additive petition was filed on December 27, 2019.
                ADDRESSES: For access to the docket, go to https://www.regulations.gov
                and insert the docket number, found in brackets in the heading of this
                document, into the ``Search'' box and follow the prompts; and/or go to
                the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville,
                MD 20852.
                FOR FURTHER INFORMATION CONTACT: Carissa Adams, Center for Veterinary
                [[Page 7683]]
                Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville,
                MD 20855, 240-402-6283, [email protected].
                SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
                Act (section 409(b)(5) (21 U.S.C. 348(b)(5))), notice is given that a
                food additive petition (FAP 2310) has been filed by LANXESS
                Corporation, 111 RIDC Park West Dr., Pittsburgh, PA 15275. The petition
                proposes to amend Title 21 of the Code of Federal Regulations (CFR) in
                part 573 (21 CFR part 573) Food Additives Permitted in Feed and
                Drinking Water of Animals to provide for the safe use of calcium
                formate as a feed acidifying agent, to lower the pH, in complete feeds
                for swine or poultry.
                 The petitioner has claimed that this action is categorically
                excluded under 21 CFR 25.32(r) because it is of a type that does not
                individually or cumulatively have a significant effect on the human
                environment. In addition, the petitioner has stated that, to their
                knowledge, no extraordinary circumstances exist. If FDA determines a
                categorical exclusion applies, neither an environmental assessment nor
                an environmental impact statement is required. If FDA determines a
                categorical exclusion does not apply, we will request an environmental
                assessment and make it available for public inspection.
                 Dated: February 5, 2020.
                Lowell J. Schiller,
                Principal Associate Commissioner for Policy.
                [FR Doc. 2020-02664 Filed 2-10-20; 8:45 am]
                 BILLING CODE 4164-01-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT